Home/Gryphon Bio/Will Haskins, PhD

WH

Will Haskins, PhD

CEO & Co-Founder

Therapeutic Areas

Traumatic Brain Injury Alzheimer's Disease Mild Cognitive Impairment

Gryphon Bio Pipeline

Drug	Indication	Phase
Blood Biomarker Panel for TBI	Traumatic Brain Injury (Monitoring & Detection)	Clinical Studies
Blood Biomarker Panel for AD/MCI	Alzheimer's Disease / Mild Cognitive Impairment	Clinical Studies

Leadership Team at Gryphon Bio

Anthony DeLizza, MS

Chief Business Officer

Devin Jackson, PhD

Senior Research Scientist

Kristy Radeker, MSM

Associate Director, Clinical Operations & Finance

Research Associate

View full Gryphon Bio profile